All In Biotech

Drug Trial Radar · NCT05552274

FTIH of ECC4703 in Healthy Volunteers

A Randomized, Double-Blind, Placebo-Controlled, Single and Repeated Dose Escalation, FTIH Study to Investigate the Safety, Tolerability, PK and PD of ECC4703 in Healthy Volunteers and Participants With Treatment-Unnecessary LDL-C Under 160 mg/dL

Last checked: Nov 19, 2026Latest source record: Jul 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

75

Actual

Start

Aug 16, 2022

Primary completion

Oct 26, 2023

Study completion Oct 26, 2023

Sponsor

Lead sponsor
EccogeneIndustry
Sponsor type
Industry
First posted
Sep 23, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a Phase 1, randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study of ECC4703 in healthy volunteers and participants with treatment unnecessary LDL-C under 160 mg/dL

Conditions

  • Non-alcoholic Steatohepatitis (NASH)

Interventions

  • ECC4703Drug

    ECC4703 will be administered as 1 mg, 10 mg and 40 mg capsules. ECC4703 will be administered as oral capsules during each dosing day.

  • PlaceboDrug

    Matching Placebo will be administered as oral capsules. Matching Placebo will be given orally during each dosing day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with adverse events, with abnormal laboratory test results, abnormal ECGs, abnormal vital signs, and abnormal physical examinationsTime frame: SAD: Up to 8 days and MAD: Up to 21 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Eccogene Investigational Site

    Las Vegas, Nevada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.